Imaging Agent of Alzheimer's Disease, Chronic Traumatic Encephalopathy and Other Neurodegenerative Diseases
CereMark Pharma to Commence Phase 3 FDA Clinical Study
Source: einnews.com
📰 Williamc Putnam News
Williamc Putnam News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Williamc Putnam. Real-time updates on events, politics, business and more.
Patent Award Notice: PET Scan Imaging Agent Detects both Tau Aggregates and Beta Amyloid Plaque Simultaneously
Share this article Share this article LEXINGTON, Ky., April 30, 2021 /PRNewswire/ -- CereMark Pharma, LLC (CereMark) has been notified by the University of California Los Angeles (UCLA) that a U.S. patent is awarded to UCLA for Flornaptitril, a PET scan imaging radiopharmaceutical which is licensed exclusively to CereMark. Flornaptitril binds with both tau aggregates and beta amyloid plaque to enhance PET scan imaging of these pathological proteins in the brain. CereMark clinical studies show t...
Source: prnewswire.com